April 12, 2024
For Immediate Release: May 23, 2019 Today, the U.S. Food and Drug Administration authorized marketing of a diagnostic test to detect Zika virus immunoglobulin (IgM) antibodies […]
April 11, 2024
Who is affected by high blood pressure? Nearly half, more than 119 million, American adults have high blood pressure. But only about 1 in 4 of […]
April 11, 2024
Benralizumab is now approved by the US Food and Drug Administration for the treatment of asthma in children older than 6 years. Marketed as Fasenra, the […]
April 11, 2024
To promote shared learning and understanding with external stakeholders, FDA continues to oversee and support numerous demonstration (i.e., research) projects on Digital Health Technologies (DHTs) through […]
April 11, 2024
With the start of GDUFA III in FY 2023, the Generic Drugs Program monthly and quarterly activities reports were combined into one report. Also, reported metrics […]
April 11, 2024
TOPLINE: Breaking up long sitting periods with short, frequent bouts of light-intensity walks may reduce the increased levels of postprandial vascular inflammatory biomarkers seen in people […]
April 11, 2024
HOW TO USE THIS SNAPSHOTThe information provided in Snapshots highlights who participated in the key clinical trials that supported the original FDA approval of this drug, […]
April 11, 2024
BUDAPEST — Changing the way that psychiatric care is delivered can significantly reduce the use of coercive measures, experts said at the 32nd European Congress of […]
April 11, 2024
On this page As displayed in the Federal Register notice on October 20, 2022, FDA is continuing the Complex Innovative Trial Design (CID) Paired Meeting Program, […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134
Next page